KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Accounts Payables (2016 - 2026)

Cme has reported Accounts Payables over the past 18 years, most recently at $75.4 million for Q1 2026.

  • Quarterly Accounts Payables fell 24.75% to $75.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $75.4 million through Mar 2026, down 24.75% year-over-year, with the annual reading at $71.8 million for FY2025, 10.14% down from the prior year.
  • Accounts Payables was $75.4 million for Q1 2026 at Cme, up from $71.8 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $129.9 million in Q3 2024 and troughed at $50.9 million in Q2 2023.
  • The 5-year median for Accounts Payables is $90.6 million (2023), against an average of $88.6 million.
  • Biggest five-year swings in Accounts Payables: surged 148.77% in 2022 and later plummeted 43.37% in 2023.
  • Tracing CME's Accounts Payables over 5 years: stood at $121.4 million in 2022, then dropped by 25.37% to $90.6 million in 2023, then dropped by 11.81% to $79.9 million in 2024, then decreased by 10.14% to $71.8 million in 2025, then grew by 5.01% to $75.4 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $75.4 million, $71.8 million, and $74.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.